Platinum amine coordination compounds as anti-tumor drugs. Molecular aspects of the mechanism of action
- 1 January 1987
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 124 references indexed in Scilit:
- Interindividual human variation in cisplatinum sensitivity, predictable in an in vitro assay?Mutation Research Letters, 1987
- A high melting cis- [Pt(NH3)2 {d(GpG)}]adduct of a decanucleotide duplexBiochemical and Biophysical Research Communications, 1986
- Cisplatin: a review of clinical applications and renal toxicityInternational Journal of Clinical Pharmacy, 1985
- Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationBiochemistry, 1985
- The structure of cis -platinum trinucleoside diphosphate species; the influence of ligand substitutions upon the conformation of the adductsRecueil des Travaux Chimiques des Pays-Bas, 1984
- Specific platinum chelation by the guanines of the deoxyhexanucleotide d(T-G-G-C-C-A) upon reaction with cis-[Pt(NH3)2(H2O)2](NO3)2Biochemical and Biophysical Research Communications, 1982
- Kinetic analysis of the in vitro binding of radioactive cis- and trans-dichlorodiammineplatinum(II) to DNAChemico-Biological Interactions, 1980
- Interaction of the anti-tumour drug cis-Pt(en)Cl2 with cytidilyl-3′ → 5′-guanosineBioinorganic Chemistry, 1978
- The nature of cis amine Pd(II) and antitumor cis amine Pt(II) complexes in aqueous solutionsJournal of Inorganic and Nuclear Chemistry, 1976
- Resolution of α, β and γ DNA of Saccharomyces cerevisiae with the antitumor drug cis-Pt(NH3)2Cl2. Evidence for preferential drug binding by GpG sequences of DNAJournal of Molecular Biology, 1976